Dasatinib inducerede immunosuppression hos mus, som var dosisrelateret og effektivt kunne behandles med dosisreduktion og/ eller ændringer dosisskemaet.
In mice, dasatinib induced immunosuppression, which was dose-related and effectively managed by dose reduction and/ or changes in dosing schedule.